Doctor profile · Federal record
Dr. Caleb Scheckel, D.O.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Internal Medicine Physician · Hematology & Oncology Physician · Tulsa, OK
- NPI 1447606348
- Accepts Medicare
- 10 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
12697 E 51St St
Tulsa, OK 741466236
(918) 505-5320
fax (918) 505-3225 - Mailing address
-
200 1St St Sw
Rochester, MN 559050001
Credentials & registration
- NPI registered
- May 2016 — 10 yrs on file
- Profile last updated
- March 14, 2023
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (3)
- Oklahoma #7579 · Arizona #007342 · Minnesota #65515
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1447606348. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
99,262
Distinct HCPCS
10
Medicare allowed
$1,959,823
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 14,201 | 160 | $0 | |
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 8,580 | 11 | $0 | |
J1627 |
Injection, granisetron, extended-release, 0.1 mg | 8,100 | 61 | $6 | |
J9299 |
Injection, nivolumab, 1 mg | 7,960 | 17 | $30 | |
J0185 |
Injection, aprepitant, 1 mg | 7,670 | 40 | $2 | |
J9271 |
Injection, pembrolizumab, 1 mg | 7,000 | 19 | $54 | |
J9267 |
Injection, paclitaxel, 1 mg | 6,208 | 24 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 5,400 | 15 | $48 | |
J1930 |
Injection, lanreotide, 1 mg | 2,520 | 13 | $56 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,497 | 136 | $0 |
In context: peer comparison
Among 18 peers in Tulsa Hematology & Oncology Physician, average services per provider: 1,283. This provider delivers 77× the peer median.Open Payments
Industry payments received
All-time total
$45,787
Transactions
54
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 17 | $21,861.04 | |
| BeiGene USA, INC. | 16 | $16,739.07 | |
| Abbvie INC. | 3 | $3,315.67 | |
| Novartis Pharmaceuticals Corporation | 4 | $2,161.31 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $1,432.50 | |
| Astellas Pharma US INC | 3 | $63.96 | |
| Genmab U.S., INC. | 1 | $33.16 | |
| Ipsen Biopharmaceuticals, INC | 2 | $32.46 | |
| Pfizer INC. | 1 | $25.53 | |
| Bayer Healthcare Pharmaceuticals INC. | 1 | $25.31 | |
| Janssen Biotech, INC. | 1 | $24.57 | |
| Daiichi Sankyo INC. | 1 | $22.57 | |
| Celgene Corporation | 1 | $17.92 | |
| Merck Sharp & Dohme LLC | 1 | $16.64 | |
| GlaxoSmithKline, LLC. | 1 | $15.62 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
802
Patients
232
Total drug cost
$2,237,413
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 143 | 37 | $2,428 |
| Levofloxacin | Generic | 73 | 34 | $1,191 |
| Venclexta (Venetoclax) | Brand | 64 | 19 | $322,453 |
| Prednisone | Generic | 60 | 19 | $467 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 58 | 11 | $2,477 |
| Ondansetron Odt (Ondansetron) | Brand | 53 | 23 | $1,073 |
| Oxycodone Hcl | Generic | 50 | 19 | $1,019 |
| Revlimid (Lenalidomide) | Brand | 49 | 12 | $982,199 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 49 | 21 | $437 |
| Fluconazole | Generic | 46 | 18 | $1,617 |
Hospital affiliations
Frequently asked questions
What is Dr. Caleb Scheckel's medical specialty?
Dr. Caleb Scheckel practices Hematology & Oncology Physician in Tulsa, OK.
Where does Dr. Caleb Scheckel practice?
Dr. Caleb Scheckel practices at 12697 E 51St St, Tulsa, OK 741466236. Office phone: 9185055320.
What is Dr. Caleb Scheckel's NPI?
Dr. Caleb Scheckel's National Provider Identifier (NPI) is 1447606348, issued by NPPES.
Does Dr. Caleb Scheckel accept Medicare assignment?
Yes. Dr. Caleb Scheckel accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Caleb Scheckel commonly perform?
Top Medicare-reported procedures in 2023: Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967); Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, granisetron, extended-release, 0.1 mg (HCPCS J1627). Source: CMS Medicare Physician & Other Practitioners file.